Dyadic International, Inc. Stock Other OTC
Equities
US26745T1016
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 4.2M | Sales 2025 * | 6.1M | Capitalization | 43.86M |
---|---|---|---|---|---|
Net income 2024 * | -22M | Net income 2025 * | -31M | EV / Sales 2024 * | 10.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.19 x |
P/E ratio 2024 * |
-2.27
x | P/E ratio 2025 * |
-1.67
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.91% |
Latest transcript on Dyadic International, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Mark Emalfarb
FOU | Founder | 69 | 78-12-31 |
Ping Rawson
DFI | Director of Finance/CFO | 48 | 16-05-31 |
Joseph Hazelton
COO | Chief Operating Officer | 48 | 21-11-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Emalfarb
FOU | Founder | 69 | 78-12-31 |
Jack Kaye
BRD | Director/Board Member | 80 | 15-04-30 |
Michael Tarnok
BRD | Director/Board Member | 69 | 14-06-11 |
1st Jan change | Capi. | |
---|---|---|
+24.64% | 48.09B | |
+46.90% | 40.62B | |
-3.17% | 40.43B | |
-6.20% | 28.36B | |
+9.39% | 24.89B | |
-20.36% | 19.01B | |
+28.59% | 12.09B | |
+0.64% | 11.88B | |
-1.21% | 11.8B |